"Aminolevulinic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
| Descriptor ID |
D000622
|
| MeSH Number(s) |
D02.241.755.547.276 D12.125.262
|
| Concept/Terms |
Aminolevulinic Acid- Aminolevulinic Acid
- Acid, Aminolevulinic
- Delta-Aminolevulinic Acid
- Acid, Delta-Aminolevulinic
- Delta Aminolevulinic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aminolevulinic Acid".
Below are MeSH descriptors whose meaning is more specific than "Aminolevulinic Acid".
This graph shows the total number of publications written about "Aminolevulinic Acid" by people in this website by year, and whether "Aminolevulinic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aminolevulinic Acid" by people in Profiles.
-
L-amino acid oxidase-1 is involved in the gut-liver axis by regulating 5-aminolevulinic acid production in mice. J Vet Med Sci. 2023 Jun 14; 85(6):672-679.
-
Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study. Urol Oncol. 2022 08; 40(8):382.e1-382.e6.
-
Macro and microeconomics of blue light cystoscopy with CYSVIEW? in non-muscle invasive bladder cancer. Urol Oncol. 2022 01; 40(1):10.e7-10.e12.
-
5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Sci Rep. 2020 10 14; 10(1):17237.
-
5-ALA-assisted stereotactic brain tumor biopsy improve diagnostic yield. Eur J Surg Oncol. 2019 Dec; 45(12):2375-2378.
-
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018. Nat Rev Urol. 2019 06; 16(6):377-386.
-
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study. BJU Int. 2019 01; 123(1):35-41.
-
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study. J Urol. 2018 05; 199(5):1158-1165.
-
Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapy. Photodiagnosis Photodyn Ther. 2018 Mar; 21:28-35.
-
Highly sensitive fluorescence detection of metastatic lymph nodes of gastric cancer with photo-oxidation of protoporphyrin IX. Eur J Surg Oncol. 2016 Aug; 42(8):1236-46.